Neurogene (NGNE) Long-Term Investments (2014 - 2017)

Neurogene's Long-Term Investments history runs 4 years deep, the most recent figure standing at $20.0 million for Q1 2017.

• Quarterly Long-Term Investments fell 48.2% year-over-year to $20.0 million in Q1 2017, while the trailing twelve-month figure through Mar 2017 was $20.0 million (down 48.2% YoY) and the FY2016 annual result came in at $50.0 million, up 30.13% from the prior year.
• Long-Term Investments was $20.0 million for Q1 2017 at Neurogene, down from $50.0 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $50.0 million in Q4 2016 and bottomed at $2.0 million in Q4 2014.
• A 4-year average of $24.8 million and a median of $20.0 million in 2017 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2015 — Long-Term Investments jumped 1820.02% — and 2017, when it slumped 48.2%.
• Neurogene's Long-Term Investments stood at $2.0 million in 2014, then soared by 1820.02% to $38.5 million in 2015, then jumped by 30.13% to $50.0 million in 2016, then sank by 60.02% to $20.0 million in 2017.
• Business Quant data shows NGNE's Long-Term Investments at $20.0 million in Q1 2017, $50.0 million in Q4 2016, and $16.7 million in Q3 2016.